Selection and characterization of the novel anti-human PD-1 FV78 antibody from a targeted epitope mammalian cell-displayed antibody library-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Selection and characterization of the novel anti-human PD-1 FV78 antibody from a targeted epitope mammalian cell-displayed antibody library

Published:2016-08-08 Issue:2 Volume:15 Page:146-157
ISSN:1672-7681
Container-title:Cellular & Molecular Immunology
language:en
Short-container-title:Cell Mol Immunol

Author:

Luo Longlong,Wang Shi,Lang Xiaoling,Zhou Tingting,Geng Jing,Li Xinying,Qiao Chunxia,Feng Jiannan,Shen Beifen,Lv Ming,Li Yan

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/cmi201638.pdf

Reference31 articles.

1. Carter PJ . Potent antibody therapeutics by design. Nat Rev Immunol 2006; 6: 343–357.

2. Presta LG . Molecular engineering and design of therapeutic antibodies. Curr Opin Immunol 2008; 20: 460–470.

3. Forsyth CM, Juan V, Akamatsu Y, DuBridge RB, Doan M, Ivanov AV et al. Deep mutational scanning of an antibody against epidermal growth factor receptor using mammalian cell display and massively parallel pyrosequencing. mAbs 2013; 5: 523–532.

4. Amit AG, Mariuzza RA, Phillips SE, Poljak RJ . Three-dimensional structure of an antigen-antibody complex at 2.8A resolution. Science 1986; 233: 747–753.

5. Jones PT, Dear PH, Foote J, Neuberger MS, Winter G . Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 1986; 321: 522–525.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction and application of a multifunctional CHO cell platform utilizing Cre/lox and Dre/rox site-specific recombination systems;Frontiers in Bioengineering and Biotechnology;2023-12-20

2. Anti-Claudin18.2-IL-21 fusion protein bifunctional molecule has more powerful anti-tumor effect and better safety;International Immunopharmacology;2023-02

3. PD-1/LAG-3 bispecific antibody potentiates T cell activation and increases antitumor efficacy;Frontiers in Immunology;2022-11-28

4. Insights into mechanisms of graft-versus-host disease through humanised mouse models;Bioscience Reports;2022-09

5. Structure-guided affinity maturation of a novel human antibody targeting the SARS-CoV-2 nucleocapsid protein;Scientific Reports;2022-05-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3